Am J Transplant, Volume 19, Suppl 3 Archives - Page 32 of 214 - ATC Abstracts

2019 American Transplant Congress
Severe Acute Rejection In Human Leukocyte Antigen Identical Renal Transplants: Reviving Mixed Lymphocyte Culture
P. Rajendran¹, M. Cusick², S. Dhingra³, B. Murthy¹
¹Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ³Pathology, Baylor College of Medicine, Houston, TX
*Purpose: Human leukocyte antigen-identical renal transplants among siblings account for a minority of all renal transplants, but have excellent long-term outcomes due to very minimal…
2019 American Transplant Congress
The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN
D. Deborska-Materkowska¹, A. Perkowska-Ptasinska¹, M. Ciszek¹, P. F. Halloran², M. Myslak³
¹Warsaw Medical University, Warsaw, Poland, ²ATAGC, University of Alberta, Edmonton AB, AB, Canada, ³Pomeranian Medical University, Szczecin, Poland
*Purpose: Anti-rejection treatment implementation is highly dependent on morphologic lesions interpretation based on Banff classification. Unfortunately, some light microscopic phenotypes are ambiguous which constricts the…
2019 American Transplant Congress
Alterations in Brain Metabolites before and after Kidney Transplant
A. Gupta¹, P. Lee², R. Lepping³, A. Jurgensen¹, J. Klein¹, P. Adany⁴, D. Cibrik¹, J. Burns⁵, W. Brooks³, I. Choi⁶
¹Division of Nephrology, The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, ²Hoglund Brain Imaging Center, Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, ³Hoglund Brain Imaging Center, Alzheimer’s Disease Center,, University of Kansas Medical Center, Kansas City, KS, ⁴Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, KS, ⁵Alzheimer’s Disease Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS, ⁶Hoglund Brain Imaging Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS
*Purpose: End stage renal disease (ESRD) is associated with accumulation of uremic metabolites and poor cognitive performance. Alterations in brain metabolites are associated with cognitive…
2019 American Transplant Congress
Cardiac Risk Assessment in Kidney Transplant Candidates: Clinical Usefulness of Different Guidelines
A. Velioglu¹, S. Mehdiyev¹, H. Arikan¹, E. Asicioglu¹, A. Cincin², S. Tuglular¹
¹Nephrology, Marmara University School of Medicine, Istanbul, Turkey, ²Cardiology, Marmara University School of Medicine, Istanbul, Turkey
*Purpose: Despite cardiovascular (CV) assessment recommended all kidney transplant recipients to minimize perioperative risk, the utility and reliability of various assessments are not well established.…
2019 American Transplant Congress
Epitope-Based Matching in Pediatric Kidney Transplantation
C. Boussard¹, M. Ould Rabah², O. Boyer², M. Macher¹, J. Taupin³, J. Hogan⁴
¹Department of Pediatric Nephrology, Robert Debre hospital, APHP, Paris, France, ²Department of Pediatric Nephrology, Necker Enfants-Malades, APHP, Paris, France, ³Department of Immunology, Saint-Louis Hospital, APHP, Paris, France, ⁴Transplant Research Center, Department of Surgery, Emory University, ATLANTA, GA
*Purpose: Following the allocation of a transplant by the allocation system, each pediatric transplant team reviews the proposal and decides based on various criteria whether…
2019 American Transplant Congress
Impact of Six-Month Surveillance Biopsies and Monitoring on 2-Year Outcomes in Pediatric Renal Transplant Recipients
J. Lyons¹, D. Ranch², R. Hall¹, P. Maxwell¹, K. Hitchman², B. Crowther¹
¹University Health System, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, Austin, TX, The University of Texas Health Science Center at San Antonio, San Antonio, TX, ²University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX
*Purpose: Evaluate the utility of surveillance biopsies on post-transplant outcomes.*Methods: A retrospective single center chart review of pediatric renal transplant recipients from 01/2011-10/2015 was conducted.…
2019 American Transplant Congress
The Association of BK Virus Infection and Risk of Subsequent Cytomegalovirus Infection after Renal Transplant
M. R. Jorgenson, J. L. Descourouez, B. Lyu, B. C. Astor, C. M. Saddler, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Cytomegalovirus (CMV) and BK polyoma virus are opportunistic infections after renal transplant (RTX) that have negative allograft outcomes. Immunosuppressive reduction is the mainstay of…
2019 American Transplant Congress
Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation
S. Rehman¹, J. Pryor², A. Olyaei³, M. Stack¹, D. Norman¹, J. Lockridge¹
¹Medicine/Nephrology, Oregon Health and Science University, Portland, OR, ²Oregon Health and Science University, Portland, OR, ³Pharmacy, Oregon Health and Science University, Portland, OR
*Purpose: To describe the characteristics of patients presenting with late BK viremia (>1 year after transplant) and compare to early BK viremia*Methods: This study was…
2019 American Transplant Congress
Early Allograft Dysfunction in High Acuity Liver Transplant Recipients
T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Organ recipient matching in Liver Transplantation (LT) has become ever-more challenging with the ongoing organ scarcity and increasing patient acuity. While the notion that…
2019 American Transplant Congress
Liver Transplant Candidates Derive a Survival Benefit from Accepting a Macrosteatotic Liver
K. Jackson, M. Bowring, C. Haugen, C. Holscher, L. Liyanage, S. Ottmann, B. Philosophe, A. Massie, D. Segev, A. Cameron, J. Garonzik-Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Accepting a liver with macrosteatosis might increase the risk of adverse post-transplant outcomes, however candidates who decline must then wait for an uncertain future…